These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6396028)

  • 21. [Ophthalmosonographic assessment of carotid atherosclerosis (author's transl)].
    Czajkowski J
    Klin Oczna; 1980 Feb; 82(2):93-5. PubMed ID: 7382327
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of patients with cerebral and diffuse arteriosclerosis with hydergine].
    Avena G
    Hospital (Rio J); 1970 Sep; 78(3):901-28. PubMed ID: 4994595
    [No Abstract]   [Full Text] [Related]  

  • 23. Flunarizine in microdrepanocytic disease.
    Finelli C; Ricci P; Visani G
    Haematologica; 1984; 69(2):233-4. PubMed ID: 6429009
    [No Abstract]   [Full Text] [Related]  

  • 24. [The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology].
    Ciammaichella A; Solitro A; Torcia L; Arcuri P
    Clin Ter; 1978 Mar; 84(5):509-21. PubMed ID: 648104
    [No Abstract]   [Full Text] [Related]  

  • 25. Preliminary results in the treatment of the unstable bladder with Flunarizine.
    Tosto A; Rinnovati A; Rizzo M
    Acta Urol Belg; 1983; 51(3):300-3. PubMed ID: 6624619
    [No Abstract]   [Full Text] [Related]  

  • 26. [Polyunsaturated phosphatidyl choline (EPL) in the treatment of cerebral arteriosclerosis and arteriosclerosis of the lower extremities].
    Ciammaichella A; Solitro A; Arcuri P
    Clin Ter; 1975 Jul; 74(1):55-62. PubMed ID: 1222517
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of flunarizine on positional nystagmus].
    Petrone D; Riondino R; Fiorella R
    Boll Soc Ital Biol Sper; 1983 Jul; 59(7):903-8. PubMed ID: 6626332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of vertebrobasilar insufficiency with flunarizine (author's transl)].
    Hofferberth B
    Arzneimittelforschung; 1980; 30(10):1817-9. PubMed ID: 7192120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Magnetic resonance in basilar atherothrombosis. Clinicopathological correlation].
    Escobar A; Isunza A; Anaya M; Escobar W
    Gac Med Mex; 1998; 134(2):247-9. PubMed ID: 9619003
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnosis of latent atherosclerotic stenosing lesions of large cerebral blood vessels in the flight personnel].
    Semenov BKh; Arapova LV; Zhevlakova LA; Parmenov-Trifilov BI
    Kosm Biol Aviakosm Med; 1983; 17(6):75-7. PubMed ID: 6656194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Migraine prevention by a calcium channel blocker. Results of a double-blind study of flunarizine vs. pizotifen].
    Wörz R; Drillisch C
    MMW Munch Med Wochenschr; 1983 Jul; 125(32-33):711-14. PubMed ID: 6415411
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of flunarizine on chronic cerebrovascular insufficiency: experience of a geriatric department].
    Ronchini P; D'Ambrosio E; Anesi E; Pellicioni P
    G Clin Med; 1982 Feb; 63(2):131-9. PubMed ID: 7106462
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of peripheral and cerebral circulation disorders. Experiences with bencyclan-hydrogenfumarate (Fludilat)].
    Frercks J
    Munch Med Wochenschr; 1971 Oct; 113(40):1293-8. PubMed ID: 5171108
    [No Abstract]   [Full Text] [Related]  

  • 34. Suppression of cerebral, myocardial and renal arteriosclerosis by the calcium antagonist flunarizine in hypertensive rats (Skelton model) without reduction of the high blood pressure.
    Schwabedal PE; Brügging-Schmitz G; Oestreich W; Szathmary SC
    J Hypertens Suppl; 1989 Dec; 7(6):S280-1. PubMed ID: 2632726
    [No Abstract]   [Full Text] [Related]  

  • 35. Peripheral vascular disease: cinnarizine et al.
    Drug Ther Bull; 1981 Mar; 19(7):27-8. PubMed ID: 7227205
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of grandaxin in the complex treatment of patients with initial atherosclerotic encephalopathy].
    Mints AIa; Garmash IuIu; Boĭko NR
    Vrach Delo; 1985 May; (5):96-9. PubMed ID: 4013237
    [No Abstract]   [Full Text] [Related]  

  • 37. [Eye and arteriosclerosis].
    Bettelheim H
    Wien Klin Wochenschr; 1969 Jun; 81(25):461-4. PubMed ID: 5809150
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the symptoms and treatment of the so-called presclerosis].
    Tobiasch V; Garakani R; Schauberger R
    Med Welt; 1967 Dec; 49():2973-81. PubMed ID: 5608853
    [No Abstract]   [Full Text] [Related]  

  • 39. Flunarizine: a wide spectrum prophylactic for migraine headache.
    Micieli G; Sances G; Pacchetti C; Trucco M; Magri M; Piazza D
    Int J Clin Pharmacol Res; 1984; 4(3):239-45. PubMed ID: 6490242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On the symptomatology and therapy of cerebral arteriosclerosis in general practice].
    Michaelis U
    Ther Ggw; 1966 Dec; 105(12):1593-600. PubMed ID: 4962890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.